Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vesicle trafficking 1 pseudogene 1 (VTA1P1) is a genomic DNA sequence that resembles the protein-coding gene *vesicle trafficking 1 (VTA1)* but does not encode a functional protein. Pseudogenes are typically non-functional remnants of genes that have lost their protein-coding ability through mutation and duplication events. VTA1P1 does not appear to be transcribed or translated into a protein, and there is no evidence connecting it to any biological processes, disease roles, or pharmacological activity. It is not considered a druggable target or a biomarker. Thus, while it shares sequence homology with the VTA1 gene, which is implicated in vesicle-mediated transport and endosomal sorting, VTA1P1 lacks the essential coding and structural features required for molecular function. Key points: - VTA1P1 is a pseudogene, not a protein, enzyme, receptor, transporter, or other pharmacologically relevant target. - There is nothing to indicate it is a functional biological or therapeutic target. - It lacks direct disease associations, biomarker status, or known involvement in drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vesicle trafficking 1 pseudogene 1 (VTA1P1).